Physician

Michele Henson, MD

According to 2025 Medicare claims, Michele Henson, MD (NPI: 1306993126) practices allergy/immunology in the Brunswick-St. Simons, GA market, with the plurality of this provider's patient population coming from Glynn, GA. This provider's primary affiliated billing organization is LIVE OAK ALLERGY, ASTHMA & IMMUNOLOGY, LLC (NPI: 1689066649; TIN: 472965534) and primary practice location at 31520-9998.

Henson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 388 traditional Medicare patients, billed 15,301 HCPCS/CPT codes, and received $183,862 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,076 prescription claims across 205 beneficiaries totaling $634,474 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 363 claims. Open Payments data shows 150 records totaling $2,998. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and rose steadily, from $640 to $11,014.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	26	498	$5,490
2016	216	8,821	$99,897
2017	357	21,735	$194,608
2018	397	23,298	$208,304
2019	434	24,123	$232,222
2020	448	22,171	$221,153
2021	401	18,490	$210,330
2022	403	16,605	$186,656
2023	393	15,091	$176,051
2024	388	15,301	$183,862

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	131	418	$26,000
2016	240	1,705	$654,314
2017	254	2,001	$794,463
2018	295	1,861	$934,816
2019	329	2,132	$1,136,978
2020	237	1,229	$941,684
2021	211	1,054	$641,832
2022	207	1,097	$626,285
2023	196	1,070	$533,091
2024	205	1,076	$634,474

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	246	$268,324
2017	N/R	270	$187,891
2018	N/R	335	$305,819
2019	N/R	288	$363,437
2020	N/R	333	$376,088
2021	N/R	329	$350,908
2022	N/R	275	$351,194
2023	N/R	284	$369,302
2024	11	363	$455,885

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	49	63	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	327	568	$60
95165	Professional service for preparation and provision of 1 or more antigens	157	8,702	$10
95117	Professional service for multiple injections of allergen	130	1,797	$8
95004	Test for allergy using allergenic extract	47	2,852	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	1,650	$34,306
Qvar Redihaler	Beclomethasone Dipropionate	20	1,020	$7,399
Ipratropium Bromide	Ipratropium Bromide	157	9,665	$7,073
Symbicort	Budesonide/Formoterol Fumarate	26	900	$6,581
Azelastine-Fluticasone	Azelastine/Fluticasone	21	1,170	$4,644

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	80	$284,263
J1575	Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulin	N	N/R	35	$162,434
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	11	119	$6,787
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	35	$1,275
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	66	$766

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	150	$2,998	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michele Henson, MD?

Tedicare shows public-source Medicare data for Michele Henson, MD (NPI 1306993126), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michele Henson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michele Henson, MD?

Michele Henson, MD is linked to LIVE OAK ALLERGY, ASTHMA & IMMUNOLOGY, LLC (billing NPI 1689066649) in the available physician profile data.

Does Michele Henson, MD have Open Payments data?

Michele Henson, MD has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.